awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44043976-7AB10AD4-9817-4487-8858-6AA98A37A750
Q44043976-7AB10AD4-9817-4487-8858-6AA98A37A750
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44043976-7AB10AD4-9817-4487-8858-6AA98A37A750
Phase III randomized trial of droloxifene and tamoxifen as first-line endocrine treatment of ER/PgR-positive advanced breast cancer.
P2860
Q44043976-7AB10AD4-9817-4487-8858-6AA98A37A750
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44043976-7AB10AD4-9817-4487-8858-6AA98A37A750
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
effc79e096094c8ad4a2206d393e32d2f2610448
P2860
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer.